Suppr超能文献

一家中心 15 年嗜铬细胞瘤和副神经节瘤诊治经验:新加坡视角。

A 15-year pheochromocytoma and paraganglioma experience in a single centre: a Singapore perspective.

机构信息

Department of Endocrinology, Tan Tock Seng Hospital, Singapore.

Department of Paediatrics, KK Women's and Children's Hospital, Singapore.

出版信息

Singapore Med J. 2022 Nov;63(11):649-658. doi: 10.11622/smedj.2021135. Epub 2021 Oct 4.

Abstract

INTRODUCTION

Pheochromocytomas (PCC) and paragangliomas (PGL) are rare endocrine tumours. The objective of this study was to describe our experience with these two entities in a Singapore population.

METHODS

We identified patients with positive histopathological confirmations of PCC and PGL who were treated at a tertiary Singapore hospital between January 2000 and December 2015. The results were analysed for clinical presentations, treatment and long-term outcomes.

RESULTS

A total of 27 cases (20 PCC, 7 PGL) were identified over a 15-year period. One case of PGL developed bilateral disease on follow-up. There were 17 male and 10 female patients with a median age of 57 (range 24-77) years. A positive family history was uncommon and present in only 3.7% of patients. Uniquely, the top three presenting symptoms were abdominal discomfort, palpitations and diaphoresis. Despite adequate preoperative preparation, intraoperative haemodynamic instability occurred in 70.4% and early postoperative hypotension occurred in 11.1% of patients. After surgery, hypertension was resolved in 41.2% (7/17) and diabetes mellitus in 60% (3/5). Disease recurrence was reported in 22.2% and distant metastases in 14.8%. At the end of the follow-up period (median 35 [range 3-148] months), 70.4% were still alive.

CONCLUSION

PCC and PGL can present with a wide range of symptoms. Intraoperative haemodynamic instability was frequent despite good preoperative preparation. Disease recurrences and metastasis occurred in up to one-fifth of the patients. Genetic screening should be offered to patients with PCC and PGL.

摘要

介绍

嗜铬细胞瘤(PCC)和副神经节瘤(PGL)是罕见的内分泌肿瘤。本研究的目的是描述新加坡人群中这两种肿瘤的诊治经验。

方法

我们回顾性分析了 2000 年 1 月至 2015 年 12 月期间在一家新加坡三级医院接受治疗的经组织学证实的 PCC 和 PGL 患者。分析了患者的临床表现、治疗和长期结局。

结果

在 15 年期间共发现 27 例(20 例 PCC,7 例 PGL)患者。1 例 PGL 患者在随访中出现双侧疾病。男性 17 例,女性 10 例,中位年龄为 57 岁(范围 24-77 岁)。罕见有阳性家族史(3.7%)。值得注意的是,前 3 位主要症状为腹部不适、心悸和出汗。尽管术前准备充分,但仍有 70.4%的患者在术中出现血流动力学不稳定,11.1%的患者在术后早期出现低血压。术后,7 例(41.2%)高血压缓解,3 例(60%)糖尿病缓解。有 22.2%的患者出现疾病复发,14.8%的患者出现远处转移。随访结束时(中位时间 35 个月,范围 3-148 个月),70.4%的患者仍然存活。

结论

PCC 和 PGL 可表现出广泛的症状。尽管术前准备充分,但术中血流动力学不稳定仍很常见。多达 1/5的患者发生疾病复发和转移。应向 PCC 和 PGL 患者提供基因筛查。

相似文献

1
A 15-year pheochromocytoma and paraganglioma experience in a single centre: a Singapore perspective.
Singapore Med J. 2022 Nov;63(11):649-658. doi: 10.11622/smedj.2021135. Epub 2021 Oct 4.
2
Approach to pheochromocytoma and paraganglioma in children and adolescents: A retrospective clinical study from a tertiary care center.
J Pediatr Urol. 2021 Jun;17(3):400.e1-400.e7. doi: 10.1016/j.jpurol.2021.01.043. Epub 2021 Feb 4.
3
Pheochromocytoma/Paraganglioma: Is This a Genetic Disorder?
Curr Cardiol Rep. 2019 Jul 31;21(9):104. doi: 10.1007/s11886-019-1184-y.
5
The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes.
Hum Pathol. 2018 Jan;71:47-54. doi: 10.1016/j.humpath.2017.10.013. Epub 2017 Oct 24.
6
[Pheochromocytoma and paraganglioma].
Rev Prat. 2015 Jun;65(6):826-30.
7
Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea.
Front Endocrinol (Lausanne). 2021 Jan 29;11:610746. doi: 10.3389/fendo.2020.610746. eCollection 2020.
8
Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems.
J Clin Endocrinol Metab. 2020 Dec 1;105(12):e4661-70. doi: 10.1210/clinem/dgaa608.
9
Genetic testing in the clinical care of patients with pheochromocytoma and paraganglioma.
Curr Opin Endocrinol Diabetes Obes. 2014 Jun;21(3):166-76. doi: 10.1097/MED.0000000000000059.
10
Genotype-phenotype correlation in paediatric pheochromocytoma and paraganglioma: a single centre experience from India.
J Pediatr Endocrinol Metab. 2017 May 1;30(5):575-581. doi: 10.1515/jpem-2016-0375.

本文引用的文献

1
A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features.
Endocr J. 2020 Feb 28;67(2):141-152. doi: 10.1507/endocrj.EJ18-0486. Epub 2019 Nov 7.
2
Pheochromocytoma and Paraganglioma.
N Engl J Med. 2019 Aug 8;381(6):552-565. doi: 10.1056/NEJMra1806651.
3
SYMPATHETIC PARAGANGLIOMA: A SINGLE-CENTER EXPERIENCE FROM WESTERN INDIA.
Endocr Pract. 2019 Mar;25(3):211-219. doi: 10.4158/EP-2018-0480.
4
Pheochromocytoma Characteristics and Behavior Differ Depending on Method of Discovery.
J Clin Endocrinol Metab. 2019 May 1;104(5):1386-1393. doi: 10.1210/jc.2018-01707.
5
Treatment and outcomes in pheochromocytomas and paragangliomas: a study of 110 cases from a single center.
Endocrine. 2018 Dec;62(3):566-575. doi: 10.1007/s12020-018-1734-x. Epub 2018 Sep 15.
9
Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: A nationwide study and systematic review.
Eur J Intern Med. 2018 May;51:68-73. doi: 10.1016/j.ejim.2018.01.015. Epub 2018 Feb 1.
10
Preoperative risk factors for haemodynamic instability during pheochromocytoma surgery in Chinese patients.
Clin Endocrinol (Oxf). 2018 Mar;88(3):498-505. doi: 10.1111/cen.13544. Epub 2018 Jan 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验